about
Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinomaMonitoring the effect of belinostat in solid tumors by H4 acetylationIdentification of a small molecule inhibitor of Sir2pTranscriptional regulation of BRD7 expression by Sp1 and c-Myc.Unraveling breast cancer heterogeneity through transcriptomic and epigenomic analysis.Unraveling the regulatory connections between two controllers of breast cancer cell fateHLA-G gene repression is reversed by demethylationComparative epigenomics of human and mouse mammary tumors.Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression.Rsf-1, a chromatin remodeling protein, induces DNA damage and promotes genomic instability.Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancerOverexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma.Cross-talk between xenobiotic detoxication and other signalling pathways: clinical and toxicological consequences.Protein-protein Förster resonance energy transfer analysis of nucleosome core particles containing H2A and H2A.Z.Preparation of polyclonal antibody specific for BRD7 and detection of its expression pattern in the human fetus.The mutational landscape of adenoid cystic carcinomaThe roles of human sucrose nonfermenting protein 2 homologue in the tumor-promoting functions of Rsf-1.Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis.Epigenetics of endometriosis.The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer.Ongoing challenges in the treatment of adenoid cystic carcinoma of the head and neck.Epigenetic Determinants of Cancer.Rsf-1 overexpression serves as a prognostic marker in human hepatocellular carcinoma.Rsf-1 overexpression in human prostate cancer, implication as a prognostic marker.New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network.Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas.Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin.Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.High-level activation of transcription of the yeast U6 snRNA gene in chromatin by the basal RNA polymerase III transcription factor TFIIIC.The transglutaminase 2 gene is aberrantly hypermethylated in gliomaCancer-specific promoters for expression-targeted gene therapy: ran, brms1 and mcm5.G1/S arrest induced by histone deacetylase inhibitor sodium butyrate in E1A + Ras-transformed cells is mediated through down-regulation of E2F activity and stabilization of beta-catenin.Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells.RSF-1 overexpression determines cancer progression and drug resistance in cervical cancer.
P2860
Q24536023-A1ECBC9E-0DED-4CE1-9EC4-EE6CEF481898Q24644030-95C35ABF-BBBA-4DE3-BF78-5F7C61D73A75Q28344005-F21863CA-2BC0-4E8C-AF01-8C09D92C4A1DQ33396101-A93FDFE0-3A14-4FA6-A625-726B139F4C07Q33570282-C9558237-39CC-4B3E-8569-36F8A1C6D037Q33791223-5310B796-0BCC-4A3A-9FD6-66D785D9F4BCQ33963997-F607CF09-C1D1-494A-BF0C-5667F310BE4AQ34089646-74C1C77F-45C1-4C8B-9C39-E67C4F090137Q34322167-45228600-DAF0-4A7F-A7D5-4F8B5F27D1F1Q34352173-C64911AC-91D1-4E65-8CA4-D4C7E08B1680Q34371225-D55E2BD3-59BD-40A2-A735-2D51F95E92D8Q34839580-5DD9B2EE-6037-4996-B076-1AC6263C9128Q36020962-B18900F5-6D76-423A-B5D1-D4F71202D811Q36076369-92C42B36-AF5E-492B-9242-B5BA21921268Q36662249-D5B62911-5EE3-4236-A7EC-A52A8CA396E8Q37003447-7681434A-AB68-4249-973D-D309F52BBCF5Q37066492-CB1061C1-D140-414C-8EA1-F57610884D5BQ37453787-6A896521-525E-47B1-9F68-2E623F5646A9Q37571067-C1B75B06-6BC8-4F64-B5E0-27654D60CAE8Q38294813-963383D1-10F4-4ED7-936E-68BE58F8348CQ38430357-3A17E4E1-2614-49CC-BF97-E479797E95E2Q38837858-37D39462-DE38-41BE-AF1B-F4BB83433251Q38998210-9AEDD2D7-EA38-4DDB-8305-96805E8C7A2DQ39019436-D04AE145-D57D-4ACF-91A6-0F64287A5CA6Q39453653-823502FE-7A0C-44BC-B336-0170E47BC909Q39469747-E1282157-BB69-4857-AEDE-0C544037B7B3Q39676602-27925252-CAEA-4C9E-B1AD-60E06689EE8CQ40039538-48848849-0525-4431-97D5-4A47E87B27E1Q40763444-EFCD7B70-E266-4570-A901-70508E6E375FQ41903416-F99C2A7C-387A-4E2A-98CF-B9F97F450C21Q45885614-45671852-80FB-4549-861D-F1F891B0ED35Q53621630-1115CCC9-0812-4274-94F8-F39E5D35A7FEQ53796413-A65051DA-8178-4782-BFD5-8B042322DEDBQ54974939-DD603228-F341-44DF-885E-0EEE4D037A39
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Chromatin remodeling: why it is important in cancer.
@ast
Chromatin remodeling: why it is important in cancer.
@en
type
label
Chromatin remodeling: why it is important in cancer.
@ast
Chromatin remodeling: why it is important in cancer.
@en
prefLabel
Chromatin remodeling: why it is important in cancer.
@ast
Chromatin remodeling: why it is important in cancer.
@en
P2860
P356
P1433
P1476
Chromatin remodeling: why it is important in cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1204322
P407
P577
2001-05-01T00:00:00Z
P5875
P6179
1021939953